We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTBL
11976
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$187K ﹤0.01%
2,612
-1,007
-28% -$78.6K
EFTR
11977
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$187K ﹤0.01%
531
-23,621
-98% -$7.62M
RTPYU
11978
DELISTED
Reinvent Technology Partners Y Unit
RTPYU
$187K ﹤0.01%
18,559
-286,886
-94% -$2.88M
AROC icon
11979
CALL
Archrock
AROC
$5.95B
$186K ﹤0.01%
22,600
+2,800
+14% +$22.5K
MPX
11980
CALL
DELISTED
Marine Products Corp
MPX
$186K ﹤0.01%
14,900
-3,800
-20% -$55.4K
MTA
11981
PUT
Metalla Royalty & Streaming
MTA
$784M
$186K ﹤0.01%
27,300
-8,000
-23% -$61.7K
ORGN
11982
PUT
DELISTED
Origin Materials
ORGN
$186K ﹤0.01%
910
-1,173
-56% -$242K
PKE icon
11983
CALL
Park Aerospace
PKE
$822M
$186K ﹤0.01%
+13,600
New +$199K
XERS icon
11984
Xeris Biopharma Holdings
XERS
$1.4B
$186K ﹤0.01%
75,834
+1,592
+2% +$4.62K
BODI icon
11985
The Beachbody Company
BODI
$79.2M
$186K ﹤0.01%
674
-24,326
-97% -$9.73M
VTIQW
11986
DELISTED
VectoIQ Acquisition Corp. II Warrant
VTIQW
$186K ﹤0.01%
239,128
+114,128
+91% +$124K
RDBX
11987
DELISTED
Redbox Entertainment Inc. Class A Common Stock
RDBX
$186K ﹤0.01%
18,492
-589,137
-97% -$5.89M
BBDO icon
11988
Banco Bradesco
BBDO
$34.8B
$185K ﹤0.01%
+61,312
New +$214K
RTB
11989
RTB Digital
RTB
$230M
$185K ﹤0.01%
+63
New +$211K
SHO icon
11990
PUT
Sunstone Hotel Investors
SHO
$2.18B
$185K ﹤0.01%
15,500
-5,700
-27% -$66.4K
TAC icon
11991
PUT
TransAlta
TAC
$4.01B
$185K ﹤0.01%
17,500
-5,700
-25% -$57.1K
ATYR
11992
CALL
aTyr Pharma
ATYR
$51.9M
$185K ﹤0.01%
20,400
+5,900
+41% +$35.3K
AEACW
11993
DELISTED
Authentic Equity Acquisition Corp. Warrant
AEACW
$185K ﹤0.01%
272,394
+20,417
+8% +$15.2K
XPRO icon
11994
Expro Ltd
XPRO
$1.83B
$184K ﹤0.01%
10,419
-32,063
-75% -$544K
ITAC
11995
DELISTED
Industrial Tech Acquisitions, Inc. Class A common stock
ITAC
$184K ﹤0.01%
18,537
+3,289
+22% +$33K
GNLN icon
11996
PUT
Greenlane Holdings
GNLN
$1.23M
0
INTT icon
11997
CALL
inTEST
INTT
$179M
$183K ﹤0.01%
+15,900
New +$212K
OPRA
11998
PUT
Opera Ltd
OPRA
$1.78B
$183K ﹤0.01%
20,700
-16,300
-44% -$158K
RDHL
11999
Redhill Biopharma
RDHL
$4.07M
$183K ﹤0.01%
+40
New +$271K
VNDA icon
12000
CALL
Vanda Pharmaceuticals
VNDA
$306M
$183K ﹤0.01%
10,700
-5,600
-34% -$98.1K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.